FDA-Inspected Site

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)

15 FDA inspections are on record for SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) in Dresden, Germany.

483· Form 483 issued

Dresden, Germany · Last updated July 9, 2026

Overview

  • 15 FDA inspections are on record.
  • 11 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-03-15.

At a glance

Inspections

15

Form 483s

11

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Mar 2024 – 15 Mar 2024Biologics483View 483 →
12 Sep 2022 – 20 Sep 2022Biologics483On file
27 Jun 2019 – 5 Jul 2019BiologicsClean
19 Jun 2017 – 27 Jun 2017Biologics483On file
11 May 2015 – 19 May 2015Biologics483On file
20 Jun 2013 – 27 Jun 2013Biologics483On file
22 Jun 2011Not recorded483On file
5 May 2011Not recorded483On file
24 May 2010Not recorded483On file
30 Apr 2009Not recorded483On file
3 Jul 2008Not recorded483On file
1 Apr 2008Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

15 Mar 2024
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Unnee Ranjan, Thai D Truong

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 11 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat